NM_001101648.2:c.-133A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001101648.2(NPC1L1):c.-133A>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 759,692 control chromosomes in the GnomAD database, including 31,190 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4712 hom., cov: 33)
Exomes 𝑓: 0.28 ( 26478 hom. )
Consequence
NPC1L1
NM_001101648.2 upstream_gene
NM_001101648.2 upstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.434
Publications
30 publications found
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPC1L1 | NM_001101648.2 | c.-133A>G | upstream_gene_variant | ENST00000381160.8 | NP_001095118.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPC1L1 | ENST00000381160.8 | c.-133A>G | upstream_gene_variant | 1 | NM_001101648.2 | ENSP00000370552.3 | ||||
| NPC1L1 | ENST00000289547.8 | c.-133A>G | upstream_gene_variant | 1 | ENSP00000289547.4 | |||||
| NPC1L1 | ENST00000546276.5 | c.-133A>G | upstream_gene_variant | 1 | ENSP00000438033.1 | |||||
| NPC1L1 | ENST00000423141.1 | c.-133A>G | upstream_gene_variant | 1 | ENSP00000404670.1 |
Frequencies
GnomAD3 genomes AF: 0.219 AC: 33315AN: 152094Hom.: 4712 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
33315
AN:
152094
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.280 AC: 170341AN: 607480Hom.: 26478 AF XY: 0.280 AC XY: 87414AN XY: 312004 show subpopulations
GnomAD4 exome
AF:
AC:
170341
AN:
607480
Hom.:
AF XY:
AC XY:
87414
AN XY:
312004
show subpopulations
African (AFR)
AF:
AC:
957
AN:
16148
American (AMR)
AF:
AC:
5018
AN:
21820
Ashkenazi Jewish (ASJ)
AF:
AC:
4151
AN:
14900
East Asian (EAS)
AF:
AC:
383
AN:
31584
South Asian (SAS)
AF:
AC:
12283
AN:
49428
European-Finnish (FIN)
AF:
AC:
7418
AN:
31510
Middle Eastern (MID)
AF:
AC:
1150
AN:
3896
European-Non Finnish (NFE)
AF:
AC:
130715
AN:
406738
Other (OTH)
AF:
AC:
8266
AN:
31456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5747
11494
17240
22987
28734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2328
4656
6984
9312
11640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.219 AC: 33313AN: 152212Hom.: 4712 Cov.: 33 AF XY: 0.213 AC XY: 15870AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
33313
AN:
152212
Hom.:
Cov.:
33
AF XY:
AC XY:
15870
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
2673
AN:
41550
American (AMR)
AF:
AC:
3688
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
936
AN:
3472
East Asian (EAS)
AF:
AC:
49
AN:
5176
South Asian (SAS)
AF:
AC:
1092
AN:
4832
European-Finnish (FIN)
AF:
AC:
2395
AN:
10596
Middle Eastern (MID)
AF:
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21471
AN:
67978
Other (OTH)
AF:
AC:
541
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1277
2554
3831
5108
6385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
426
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.